PLASMAKALLIKREINBINDENDE PROTEINE

Patent europeic · EP3459564 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3459564
Numer da la dumonda
EP18185298
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
06-01-2011
Publitgà
27-03-2019
Concedì
27-10-2021
La protecziun finescha il pli tard
05-01-2031
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
A61K 39/395 (2006.01)
C07K 16/18 (2006.01)
C07K 16/40 (2006.01)
Prioritad
US 29261410 P 06.01.2010
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-02-2026

    Midada

    Published in Swissreg on 01.02.2026

  2. 01-02-2025

    Midada

    Published in Swissreg on 01.02.2025

  3. 01-02-2024

    Midada

    Published in Swissreg on 01.02.2024

  4. 01-02-2023

    Midada

    Published in Swissreg on 01.02.2023

  5. 07-09-2022

    Midada

    Published in Swissreg on 07.09.2022

  6. 27-10-2021

    Concedì

    Published in Swissreg on 27.10.2021

Partidas

Possessur

Takeda Pharmaceutical Company Limited

1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka, JP

Inventur

SEXTON, Daniel J.

Melrose, MA 02176, US

VISWANATHAN, Malini

Acton, MA 01720, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.